The CEO of Novo Holdings has warned that his $160 billion fund will slow down investment activity until the dust settles ...

Tonix has no tonic for cocaine intoxication, with the biopharma terminating a midstage trial for the condition amid poor ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former ...

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer ...

Transplanting bacteria from the feces of healthy people into the guts of mice and patients with fibromyalgia successfully ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

Just over a month after laying off staff to focus on its lead cancer candidate, ALX Oncology announced that the asset ...

A retrospective study of an artificial intelligence program for reading 3D mammography scans illustrated the pros, cons and ...

Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, ...

Granite Bio is ready to rock 'n' roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting ...